A new treatment for AMD: references

Article

References

1. The World Health Organization. The World Health Report 2002-Reducing Risks, Promoting Healthy Life, pp 47-96. From the Internet @ www.who.int/whr/2002, accessed March 18, 2008.

2. National Institute for Health and Clinical Excellence (NICE). Incorporating health economics in guidelines and assessing resource impact. The Guidelines Manual, London, NICE, 2007, Chap 8. Available on the Internet @www.nice.org.uk, accessed 3-15-08.

3. Bureau of Labor and Statistics. Data on disability and unemployment. 1991/92, 1993/94, 1994/95, and 1997. From the Survey of Income and Program Participation. From the Internet @ www.bls.census.gov, accessed April 4, 2008.

4. Political calculations. Average wages in the US. http://politicalcalculations.blogspot.com, accessed 4-6-08.

5. Macular Degeneration Partnership. Available at: www.AMD.org. Accessed August 14, 2009.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.